Moolec Science
MLEC
4 hedge funds and large institutions have $39K invested in Moolec Science in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 8 → 4 (-4)
76% less capital invested
Capital invested by funds: $160K → $39K (-$121K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAAM
Baker Avenue Asset Management
San Francisco,
California
|
-$68.8K |
| 2 |
MWM
MGB Wealth Management
Addison,
Texas
|
-$23.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$18.7K |
| 4 |
PCM
Penserra Capital Management
Orinda,
California
|
-$6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$55 |
MLEC Hedge Fund Activity: Q3 2024 in Review
4 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Moolec Science (MLEC) for Q3 2024, worth a combined $39K — down 76% from $160K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MLEC and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $7.12K. The largest seller was Baker Avenue Asset Management, exiting entirely with an estimated $68.8K sold.
- 4 institutional investors held Moolec Science (MLEC) as of Q3 2024, down from 8 in Q2 2024.
- Funds reported $39K of Moolec Science stock for Q3 2024, down 76% quarter-over-quarter.
- 0 funds opened new Moolec Science positions in Q3 2024 and 4 closed out, a net change of -4 holders.
- The largest Moolec Science buyer in Q3 2024 was UBS Group, an estimated $7.12K added.
- The largest Moolec Science seller in Q3 2024 was Baker Avenue Asset Management, an estimated $68.8K sold.
Based on aggregated 13F filings for Q3 2024.